{
  "name": "atacseq-accessibility-profiling",
  "title": "ATAC-seq Chromatin Accessibility Profiling",
  "description": "Map genome-wide chromatin accessibility using ATAC-seq. Identifies open chromatin regions, TF footprints, and regulatory elements accessible for transcription.",
  "version": "1.0.0",
  "engineType": "NEXTFLOW",
  "command": "nextflow run nf-core/atacseq --input ${input} --outdir ${outdir} --genome ${genome} --read_length ${read_length} -r 2.1.2 ",
  "imageUrl": "https://raw.githubusercontent.com/nf-core/atacseq/master/docs/images/nf-core-atacseq_logo_light.png",
  "content": "<h2><strong>ATAC-seq Chromatin Accessibility</strong></h2><p><strong>ATAC-seq</strong> (Assay for Transposase-Accessible Chromatin using sequencing) maps open chromatin regions across the genome. The Tn5 transposase cuts and tags accessible DNA, revealing where chromatin is open for regulatory factors to bind.</p><h3><strong>What is ATAC-seq?</strong></h3><blockquote><p><strong>The Technique</strong>:</p><ol><li><strong>Cells/Nuclei</strong>: Start with 50K-500K cells or nuclei</li><li><strong>Tn5 Transposase</strong>: Inserts sequencing adapters into accessible DNA</li><li><strong>Fragmentation + Tagging</strong>: Simultaneously cuts and tags DNA</li><li><strong>PCR Amplification</strong>: Enrich library</li><li><strong>Sequencing</strong>: Paired-end reads show accessible regions</li><li><strong>Analysis</strong>: Map reads to identify open chromatin peaks</li></ol></blockquote><h3><strong>Why ATAC-seq?</strong></h3><ul><li><strong>Fast & Simple</strong>: No antibodies needed (unlike ChIP-seq)</li><li><strong>Low Input</strong>: Works with 500-50K cells</li><li><strong>Genome-Wide</strong>: All open chromatin, not single target</li><li><strong>Regulatory Map</strong>: Promoters, enhancers, insulators</li><li><strong>TF Footprints</strong>: Infer TF binding without ChIP</li><li><strong>Cell-Type Specific</strong>: Different chromatin states per cell type</li><li><strong>Nucleosome Positioning</strong>: Fragment size reveals nucleosome locations</li></ul><h3><strong>ATAC-seq vs Other Methods</strong></h3><table><tr><th>Feature</th><th>ATAC-seq</th><th>DNase-seq</th><th>ChIP-seq</th></tr><tr><td><strong>Cell Input</strong></td><td>500-50K</td><td>1-10M</td><td>1-10M</td></tr><tr><td><strong>Time</strong></td><td>~3 hours</td><td>~2 days</td><td>~2-3 days</td></tr><tr><td><strong>Antibodies</strong></td><td>❌ No</td><td>❌ No</td><td>✅ Yes (expensive)</td></tr><tr><td><strong>Resolution</strong></td><td>Base-pair</td><td>Base-pair</td><td>100-500bp</td></tr><tr><td><strong>Readout</strong></td><td>All open chromatin</td><td>All open chromatin</td><td>Single target</td></tr><tr><td><strong>Nucleosomes</strong></td><td>✅ Yes</td><td>❌ Limited</td><td>❌ No</td></tr></table><h3><strong>What ATAC-seq Reveals</strong></h3><p><strong>Regulatory Elements</strong>:</p><ul><li><strong>Active Promoters</strong>: Open chromatin at TSS</li><li><strong>Distal Enhancers</strong>: Accessible regulatory regions</li><li><strong>Insulators</strong>: CTCF binding sites (open chromatin)</li><li><strong>Silencers</strong>: Repressive elements</li></ul><p><strong>Transcription Factor Footprints</strong>:</p><ul><li>TFs protect DNA from Tn5 cutting → leave \"footprints\"</li><li>Infer which TFs are bound without antibodies</li><li>Computationally predict active TFs per cell type</li></ul><p><strong>Nucleosome Positioning</strong>:</p><ul><li><strong>Fragment sizes</strong>: <100bp (nucleosome-free), ~200bp (mono-nuc), ~400bp (di-nuc)</li><li><strong>Nucleosome-free regions (NFR)</strong>: At active enhancers/promoters</li><li><strong>Phased nucleosomes</strong>: Positioned arrays at regulatory elements</li></ul><h3><strong>Pipeline Analysis</strong></h3><ol><li><strong>Quality Control</strong>: FastQC checks read quality</li><li><strong>Trimming</strong>: Remove adapters (especially Tn5 adapters)</li><li><strong>Alignment</strong>: BWA/Bowtie2/STAR maps paired-end reads</li><li><strong>Filtering</strong>: Remove duplicates, mitochondrial reads, blacklisted regions</li><li><strong>Peak Calling</strong>: MACS2 identifies accessible regions</li><li><strong>Fragment Size Analysis</strong>: Nucleosome positioning from insert sizes</li><li><strong>TF Footprinting</strong>: TOBIAS or HINT-ATAC predicts TF binding</li><li><strong>Differential Accessibility</strong>: Compare conditions (DiffBind/DESeq2)</li><li><strong>Motif Enrichment</strong>: HOMER finds enriched TF motifs in peaks</li></ol><h3><strong>QC Metrics</strong></h3><ul><li><strong>TSS Enrichment</strong>: Signal at transcription start sites (should be >7)</li><li><strong>FRiP Score</strong>: Fraction of reads in peaks (should be >0.3)</li><li><strong>Fragment Size Distribution</strong>: Nucleosome-free peak + periodic nucleosomal peaks</li><li><strong>Library Complexity</strong>: NRF, PBC1, PBC2 metrics</li><li><strong>Mitochondrial %</strong>: Should be <20% (high % indicates dead cells)</li></ul><h3><strong>Scientific Questions</strong></h3><ul><li><strong>Cell Identity</strong>: What regulatory landscape defines this cell type?</li><li><strong>Activation States</strong>: How does chromatin change upon stimulus?</li><li><strong>Development</strong>: Which enhancers open during differentiation?</li><li><strong>Disease</strong>: Aberrant chromatin accessibility in cancer</li><li><strong>TF Activity</strong>: Which TFs are active without doing 100 ChIP-seq experiments?</li><li><strong>Epigenetic Drugs</strong>: Do HDAC inhibitors open chromatin?</li></ul><h3><strong>Applications</strong></h3><ul><li><strong>Cancer</strong>: Aberrant enhancer activation, oncogenic TF activity</li><li><strong>Immunology</strong>: Immune cell differentiation, T cell activation</li><li><strong>Neuroscience</strong>: Neuronal vs glial chromatin landscapes</li><li><strong>Stem Cells</strong>: Pluripotency enhancers, lineage priming</li><li><strong>Development</strong>: Temporal chromatin remodeling during embryogenesis</li><li><strong>Aging</strong>: Age-related chromatin changes</li><li><strong>Drug Discovery</strong>: Epigenetic drug effects on chromatin</li></ul><h3><strong>Input Requirements</strong></h3><p>CSV samplesheet with columns:</p><ul><li><strong>sample</strong>: Sample name</li><li><strong>fastq_1</strong>: Path to R1 FASTQ</li><li><strong>fastq_2</strong>: Path to R2 FASTQ</li><li><strong>replicate</strong>: Biological replicate number</li></ul><h3><strong>Key Outputs</strong></h3><ul><li><strong>Peak Calls</strong>: BED files with accessible regions</li><li><strong>BigWig Tracks</strong>: Genome browser visualization</li><li><strong>Fragment Size Distribution</strong>: Nucleosome positioning</li><li><strong>TF Footprints</strong>: Predicted TF binding sites</li><li><strong>Differential Peaks</strong>: Condition-specific accessibility changes</li><li><strong>Motif Enrichment</strong>: TF motifs in accessible regions</li><li><strong>QC Report</strong>: MultiQC with TSS enrichment, FRiP, etc.</li><li><strong>Consensus Peaks</strong>: Reproducible peaks across replicates</li></ul><blockquote><p><strong>Perfect for:</strong> Chromatin accessibility • Regulatory elements • TF footprints • Cell identity • Development • Disease epigenetics</p></blockquote>",
  "spec": [
    {
      "type": "Stash File",
      "label": "Sample Sheet",
      "name": "input",
      "description": "CSV with ATAC-seq samples",
      "required": true,
      "restrictions": {
        "allow_files": true,
        "allow_folders": false,
        "allowed_file_types": [".csv"]
      }
    },
    {
      "type": "Select",
      "label": "Reference Genome",
      "name": "genome",
      "description": "Reference genome",
      "defaultValue": "GRCh38",
      "required": true,
      "options": [
        {"label": "Human GRCh38", "value": "GRCh38"},
        {"label": "Mouse GRCm39", "value": "GRCm39"},
        {"label": "Human GRCh37", "value": "GRCh37"},
        {"label": "Mouse GRCm38", "value": "GRCm38"}
      ]
    },
    {
      "type": "Select",
      "label": "Read Length",
      "name": "read_length",
      "description": "Sequencing read length",
      "defaultValue": "50",
      "required": true,
      "options": [
        {"label": "50bp", "value": "50"},
        {"label": "75bp", "value": "75"},
        {"label": "100bp", "value": "100"},
        {"label": "150bp", "value": "150"}
      ]
    },
    {
      "type": "Stash File",
      "label": "Output Directory",
      "name": "outdir",
      "description": "Output directory",
      "defaultValue": "./atacseq-results",
      "required": true,
      "restrictions": {
        "allow_files": false,
        "allow_folders": true
      }
    }
  ],
  "jobConfig": [
    {
      "type": "Select",
      "label": "Compute Resources",
      "name": "system_size",
      "hidden": false,
      "options": [
        {"label": "LARGE (Recommended)", "value": "large", "mapValue": {"nodeSize": "LARGE", "numNodes": 1, "withGpu": false}}
      ],
      "defaultValue": "large"
    }
  ],
  "tags": [
    {"name": "atac-seq", "type": "field"},
    {"name": "chromatin-accessibility", "type": "task"},
    {"name": "epigenomics", "type": "task"}
  ]
}
